ADAMTSL4, a Secreted Glycoprotein, Is a Novel Immune-Related Biomarker for Primary Glioblastoma Multiforme

Table 1

Clinical and molecular characteristics of 88 patients in the CGGA cohort.

Total variables (, percentage)	pGBM ()
Age
Median (range)	49.6 (12–81)
Age ≥ 45	31 (35%)
Age < 45	56 (64%)
NA	1 (1%)
Gender
Male	55 (63%)
Female	32 (36%)
NA	1 (1%)
IDH1/2 status
Mutation	12 (14%)
Wild-type	75 (85%)
NA	1 (1%)
MGMT promoter status
Methylated	33 (38%)
Unmethylated	51 (58%)
NA	4 (4%)
Radiotherapy
Yes	58 (66%)
No	18 (20%)
NA	12 (14%)
Chemotherapy
Yes	51 (58%)
No	24 (27%)
NA	13 (15%)
TCGA subtype
Neural	7 (8%)
Proneural	13 (15%)
Classical	31 (35%)
Mesenchymal	36 (41%)
NA	1 (1%)

IDH1/2 = isocitrate dehydrogenase 1; MGMT = methylguanine methyltransferase.